News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

for the Clinical Pharmacy Cardiac Risk Service Study Group

Articles by for the Clinical Pharmacy Cardiac Risk Service Study Group

Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management

ByKari L. Olson, PharmD,Thomas Delate, PhD,Jon Rasmussen, PharmD,Tammy L. Humphries, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group

August 7th 2009

Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.

Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus

ByKaren J. McConnell, PharmD,Emily B. Zadvorny, PharmD,Anne M. Denham, PharmD,Sheila L. Kasten, PharmD,Kara A. Hutka, PharmD,Cedar R. Koetting, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group

October 1st 2007

Latest Updated Articles

Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management
August 7th 2009
Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
October 1st 2007

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access